|
CEP350 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.373200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34080000000225E-05 |
| Normal-vs-Stage2 |
1.330360E-01 |
| Normal-vs-Stage3 |
1.028200E-01 |
| Normal-vs-Stage4 |
5.511000E-01 |
| Stage1-vs-Stage2 |
3.529000E-01 |
| Stage1-vs-Stage3 |
2.170000E-01 |
| Stage1-vs-Stage4 |
3.503200E-01 |
| Stage2-vs-Stage3 |
9.024400E-01 |
| Stage2-vs-Stage4 |
8.349000E-01 |
| Stage3-vs-Stage4 |
8.825200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.844500E-04 |
| Normal-vs-AfricanAmerican |
4.943900E-03 |
| Normal-vs-Asian |
1.731510E-02 |
| Caucasian-vs-AfricanAmerican |
8.952800E-01 |
| Caucasian-vs-Asian |
5.140600E-01 |
| AfricanAmerican-vs-Asian |
7.195600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.90919999995842E-06 |
| Normal-vs-Female |
9.357200E-01 |
| Male-vs-Female |
1.359300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.088000E-02 |
| Normal-vs-Extreme_Weight |
1.98389999994664E-06 |
| Normal-vs-Obese |
6.597700E-02 |
| Normal-vs-Extreme_Obese |
7.807700E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.508960E-01 |
| Normal_Weight-vs-Obese |
5.834600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.349200E-01 |
| Extreme_Weight-vs-Obese |
2.086200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.003400E-01 |
| Obese-vs-Extreme_Obese |
7.693500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.002800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.742100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.08899999998291E-06 |
| Normal-vs-Age(81-100Yrs) |
9.92520000000496E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.376600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.380200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.936000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.265000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.567800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.836000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.21360000000059E-05 |
| Normal-VS-Type2 PRCC |
2.115500E-03 |
| Normal-VS-KIRP CIMP |
8.094800E-01 |
| Normal-VS-Unclassified PRCC |
4.659600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.132200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.099000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.940000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.478600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.409790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.283600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75398999999743E-05 |
| Normal-vs-N1 |
7.920400E-01 |
| Normal-vs-N2 |
4.897600E-01 |
| N0-vs-N1 |
1.922200E-02 |
| N0-vs-N2 |
2.095200E-01 |
| N1-vs-N2 |
6.916000E-01 |
|
|
